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ABSTRACT 
 
The loss of insulin sensitivity in Type 2 diabetes interferes with cellular utilization 
of glucose.  The underlying down-regulation of insulin receptors and the resulting insulin 
resistance is wide-spread throughout the body.  The cardiovascular consequences may be 
indirectly responsible for decreased taste sensitivity because of diminished perfusion of 
the taste buds in this patient population.  This study utilized an inexpensive, non-invasive 
technique, electrogustometry, to directly stimulate the taste buds by applying a variable, 
direct-current stimulus to measure taste receptor thresholds in newly-diagnosed (< 2 
years) and long-standing diagnosed (> 6 years) male and female Type 2 diabetes mellitus 
subjects.  Taste thresholds were elicited by application of an anodal current to the taste 
receptors.  An increased taste threshold to the anodal current, indicative of a loss of taste 
sensitivity, was detected in those Type 2 diabetes mellitus subjects with long-standing 
disease compared to newly diagnosed subjects.  Although the differences were not 
statistically significant a consistent trend suggestive of a significant difference was 
demonstrated.  The results of this pilot study suggest that a future study utilizing a larger 
number of subjects may result in statistical significance of this approach to managing 
these two groups. 
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1 
Introduction 
 The complications of Type 2 diabetes are associated with numerous pathologies 
related to the duration of this disease.  The monitoring of these complications such as 
diabetic retinopathy, neuropathy, and nephropathy present a difficult problem.  The 
current clinical evaluation of the diabetic patient includes several routine laboratory tests.  
Perhaps changes in taste thresholds may provide an additional monitoring resource in the 
future.  This study was designed to determine whether taste thresholds could be affected 
as a consequence of the progression of the disease process or a predictor of disease onset.  
It is presently unclear whether the evolution of the taste threshold differences and disease 
process in Type 1 and Type 2 diabetics occurs in a similar manner.  This study utilized an 
inexpensive, non-invasive technique, electrogustometry, to directly stimulate the taste 
buds by applying a variable, direct-current stimulus to measure taste receptor thresholds 
in newly-diagnosed (< 2 years) and long-standing diagnosed (> 6 years) male and female 
Type 2 diabetic subjects.  A better understanding of the declining changes in taste 
perception is important because individuals with diabetes often compensate for decreased 
taste sensitivity (impairment) by consuming foods higher in salt and sugar content.  This 
life-style behavior may place the individual at risk for increased blood pressure and labile 
glucose status.  The increased susceptibility to hyperglycemia and hypertension has been 
shown in observations using chemical taste testing and electrogustometry (1, 2).   
Two previous studies were carried out at the Philadelphia College of Osteopathic 
Medicine (1, 3).  The first explored taste threshold differences among non-diabetics, 
Type 1 and Type 2 diabetics.  Significant differences were found between non-diabetic 
and diabetic subjects, but no significant differences were found between Type 1 and 2 
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diabetic subjects.  The goal of the second study was to determine whether taste thresholds 
are altered in subjects with a history of diabetes among their immediate relatives.  Using 
an electrogustometer, taste thresholds of healthy 20-30 year old volunteers with and 
without a primary family history of type 2 diabetes were studied using an 
electrogustometer.  The study also compared results of the PTC (phenylthiocarbamide) 
taste test of healthy 20-30 year old volunteers with and without a primary family history 
of type 2 diabetes.  A positive primary family history of type 2 diabetes was considered 
to be parents and/or grandparents with a diagnosis of the disease.  Study participants in 
both studies were non-smokers without a history of tongue pathology.  The present study 
is designed to investigate whether there are differences in threshold taste sensitivity 
relative to the duration of the Type 2 diabetes mellitus disease. 
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Background 
Diabetes mellitus 
 Diabetes mellitus is a disease of altered carbohydrate, fat, and protein metabolism 
caused by a lack of insulin secretion from pancreatic beta cells (Type 1) or the decreased 
sensitivity of the other cells in the body to respond to insulin (Type 2) (4).  Insulin, a 
hormone secreted from the beta cells of the pancreas is responsible for glucose uptake 
from the bloodstream into insulin sensitive cells such as adipose tissue, liver and muscles 
(4).  Despite their different etiologies, both types result in hyperglycemia (high blood 
sugar) because glucose cannot be transported into the cells and remains in the blood 
stream.  The characteristics of Type 2 diabetes mellitus are hyperinsulinemia (excess 
insulin in the blood) with insulin resistance of all cells and decreased beta cell secretion 
of insulin.  However, in Type 2 diabetes mellitus, insulin resistance begins with a defect 
in the initial response to high concentrations of blood glucose.  Insufficient insulin is 
released in proportion to the concentration of plasma glucose, which results in a 
compensatory and exaggerated response resulting in increased insulin release and 
hyperinsulinemia.  If the hyperinsulinemia is sustained then the insulin receptors are 
down-regulated which causes the tissues to become less sensitive and more resistant to 
insulin action and decreases glucose uptake (5).  The glucose remains in the bloodstream 
following a meal, causing hyperglycemia as well as fasting hyperglycemic levels.   
Two other components necessary for establishing a diagnosis are excessive 
glucose production by the liver and abnormal fat metabolism (5).  A hypoglycemic state 
will cause the brain to stimulate the adrenal glands to release epinephrine and cortisol, 
pancreatic alpha cells to secrete glucagon, and the pituitary gland to release growth 
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hormone.  All three responses cause the liver to convert glycogen to glucose and the 
glucose to be released into the blood (4, 6, 7, and 8).  In regards to fat metabolism, insulin 
promotes fat synthesis and storage.  However, in the absence of insulin, fat metabolism is 
increased as an alternative form of energy since the body cannot utilize the glucose from 
the bloodstream.  There is an increase in breakdown of the stored fat into fatty acids 
which are released into the bloodstream.  The liver can convert the excess fatty acids into 
phospholipids and cholesterol which can be released into the bloodstream as lipoproteins.  
Excess lipoproteins can cause atherosclerosis, one of many complications, to develop 
over time.  
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Diabetic Complications 
 Type 2 diabetes mellitus is a chronic disease and it is important that the patient 
assume responsibility for controlling their glucose levels.  Control is difficult under even 
the best circumstances and hyperglycemia will occasionally occur, so that after five to ten 
years of the disease, complications are usually apparent.  Microvascular complications 
such as neuropathy, retinopathy, and nephropathy are predominantly mediated by periods 
of uncontrolled hyperglycemia.  According to the Diabetes Control Complications Trial 
(DCCT) (10), United Kingdom Prospective Diabetes Study (UKPDS) (11), and 
Kumamoto studies (12), hyperglycemia is the major cause of microvascular 
complications. 
Microvascular Complications 
Neuropathy 
 Neuropathy is present in about 50% of individuals with long-standing diabetes.  
The development of neuropathy is strongly correlated with the duration of the disease and 
the degree of glycemic control.  The two main types are polyneuropathy and autonomic 
neuropathy.  Distal symmetric polyneuropathy is the most common form of diabetic 
neuropathy.  Symptoms are a sensation of numbness, tingling, sharpness, or burning that 
begins in the feet and spreads proximally.  These symptoms usually involve the lower 
extremities, are present at rest, and worsen at night (5).  These symptoms eventually 
disappear in six-twelve months, but leave a sensory deficit in the lower extremities (13).  
Physical examination reveals sensory loss, loss of ankle reflexes, and abnormal position 
sense (5).  Autonomic neuropathy develops in patients who have had the disease for 
twenty years or more, and involve, the sympathetic, parasympathetic, and enteric nerves, 
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which affect the blood vessels, digestive, urinary, and reproductive systems (13).  
Clinical symptoms of autonomic neuropathy include: gustatory sweating (sweating after 
eating), low blood pressure, erectile dysfunction, bladder dysfunction, and diarrhea.  
Neuropathic complications can be minimized with effective control of blood glucose 
levels (14). 
Retinopathy 
Retinopathy is a progressive eye disease that results from damage to blood vessels 
at the back of the eye (15).  There are two types: nonproliferative and proliferative 
diabetic retinopathy.  Nonproliferative diabetic retinopathy is the first phase of the 
progression.  It occurs late in the first decade of Type 2 diabetes mellitus or early in the 
second decade.  Symptoms of the disease are retinal vascular microaneurysms, blot 
hemorrhages, and cotton wool spots.  As the retinopathy progresses there is loss of retinal 
pericytes, increased retinal vascular permeability, alterations in retinal blood flow, and 
abnormal retinal microvasculature.  All of these lead up to retinal ischemia, which is a 
reduced supply of blood to the retina.  If nothing is done to stop or slow the progression, 
the condition turns into proliferative diabetic retinopathy, the primary sign of which is 
neovascularization; the growth of new blood vessels.  Neovascularization is stimulated by 
the decreased blood flow and the retina’s requirement for oxygen and nutrients.  These 
new blood vessels occur near the optic nerve or macula, and are problematic because they 
rupture easily and can lead to retinal detachment.  The best predictors for the 
development and progression of retinopathy are the duration of diabetes and the degree of 
glycemic control (5).   
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Nephropathy 
Nephropathy, also known as kidney disease, is another microvascular 
complication.  Diabetic nephropathy is the leading cause of end stage renal disease as 
well as diabetes related morbidity and mortality.  Once again hyperglycemia is the source 
of change in function and structure of the kidney.  The progression of diabetic 
nephropathy begins at the diagnosis of diabetes.  Within the first few years, after the 
onset of diabetes, glomerular hyperperfusion and renal hypertrophy occur, especially 
associated with a high glomerular filtration rate.  The three key points to be considered 
with Type 2 diabetes mellitus and nephropathy pertain to microalbuminuria (a small 
amount of albumin in the urine), soluble factors, and structural changes:   
1.  Microalbuminuria or macroalbuminuria may be present at diagnosis when 
there is a long asymptomatic period.  Hypertension commonly accompanies the 
microalbuminuria and macroalbuminuria.  Microalbuminuria may be less predictive of 
diabetic nephropathy and the progression to macroalbuminuria in Type 2 diabetes 
mellitus.  Albuminuria may be due to other health issues unrelated to diabetes mellitus, 
including hypertension, congestive heart failure, prostate disease, or infection.  The 
progression of microalbuminuria can be slowed and controlled with increased glycemic 
control, but once macroalbuminuria sets in, the glomerular filtration rate (GFR) steadily 
declines and there is a slight rise in blood pressure.  These pathologic effects are 
irreversible; and usually result in end stage renal disease.  Strict blood pressure control 
(<130/80 mmHg) and angiotensin converting enzyme (ACE) inhibitors help reduce 
albumin excretion.  ACE inhibitors help to decrease blood pressure by dilating blood 
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vessels, but they are also helpful in delaying the progression of microalbuminuria to 
macroalbuminuria and the related decline in GFR (5).   
2.  Soluble factors such as growth factors, angiotensin II, and endothelin cause 
structural and functional changes to the kidney.  Decline in function is caused by 
glomerular hyperfiltration and glomerular hyperperfusion, which do not allow enough 
time for the kidney to adequately regulate the body’s concentrations of sodium and water.  
Because the flow through the kidney is increased, glomerular capillary pressure also 
increases (5).  
3.  Structural changes occurring in the glomerulus include increased extracellular 
matrix, with basement membrane thickening, mesangial expansion and fibrosis (5).  All 
of these factors together result in an abnormal functioning and eventual loss of kidney 
function. 
Treatment 
The treatments for Type 2 diabetes are to learn meal planning, as well as exercise 
and weight loss methods to control glucose levels.  When these efforts are not sufficient, 
insulin injections and/or medication such as, sulfonylureas, meglitinides, biguanides, 
alpha-glucosidase inhibitors, and thiazolidinedione agents are required (9).  They all 
work to decrease blood glucose but have different mechanisms of action.  
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Taste 
 Taste is a special sense.  The organs for taste are the taste buds located in the 
mucosa of the epiglottis, palate, pharynx, and tongue.  This study focuses on the taste 
buds on the tongue because of their accessibility and their distinct pattern which enables 
accurate repeated testing of specific sites.  The taste buds are found within the fungiform 
and circumvallate papillae.  The fungiform papillae are rounded structures and most 
numerous near the tip of the tongue as shown in Figure 1.   
 
Figure 1. Papillae on dorsum of the tongue (16). 
Each papilla has 5 taste buds which are located on top of the papillae.  The 
circumvallate papillae are larger, prominent structures arranged in a V near the back of 
the tongue.  The circumvallate papillae can have up to 100 taste buds, which are located 
along the sides of the papilla as shown in Figure 2. 
Each taste bud is composed of four different cell types. Basal cells, Type 1, and 
Type 2 sustentacular cells, and Type 3 cells.  Type 3 cells are the gustatory receptor cells 
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that make connections with the sensory nerve fibers that propagate the signals to the 
brain.  The Type 3 cell has microvillus that project into a taste pore, the opening of the 
taste bud to the oral cavity and the fluids present there (Figure 3). 
 
Figure 2. Schematic of the tongue and a cross section of a taste bud (16). 
                          
Figure 3.  Taste pore detail (17).  
 
Each taste bud is innervated by about 50 nerve fibers and each fiber receives input 
from 5 taste buds (17).  Taste signals are conveyed by nerves to the brain where the 
specific qualities are interpreted.  The nerves involved with the special sense of taste 
11 
include: the chorda tympani branch of the facial nerve which innervates the anterior 2/3 
of the tongue, the glossopharyngeal nerve which innervates the posterior 1/3 of the 
tongue, and the vagus nerve which innervates the other areas of the tongue.  The nerves 
responsible for general sensations are the lingual nerve which innervates the anterior 2/3 
of the tongue and the glossopharyngeal nerve which innervates the posterior 1/3 of the 
tongue (Figure 4). 
   
Figure 4. Innervations of the tongue (16). 
There are five types of taste qualities: sweet, sour, salt, bitter, and umami.  
Umami is also known as savory and when translated from Japanese means “delicious 
flavor” (18).  The five sensations of taste result from the reactions of substances with the 
chemical receptors in the taste cells; there are sodium, potassium, chloride, adenosine, 
inosine, sweet, bitter, glutamate, and hydrogen ion receptors.  Sodium, potassium, and 
chloride receptors are activated for salty foods, hydrogen ion receptors by sour foods, 
sweet receptors by sugars, and organic substances containing nitrogen activate the bitter 
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receptors.  Foods containing glutamate, such as broth and aged meats and cheeses are 
responsible for the umami taste sensation (19).  Substances must be dissolved in the fluid 
(saliva) to be sensed by the taste buds.   The fluid part of the saliva comes from the 
microvasculature surrounding the taste buds and other parts of the vascular tongue 
especially the salivary glands, parotid, submandibular, and sublingual.  Substances 
dissolved in the saliva flowing over the taste buds activate the various receptors which 
then transmit signals to the brain to be interpreted.  Contrary to previous thought, all taste 
qualities are sensed from all areas of the tongue; there is little localization of taste to a 
specific area of the tongue (17).  Since the tongue has extensive microvasculature, and 
the taste receptors depend upon stimulation by substances dissolved in an aqueous 
environment and saliva is derived from plasma, any disease affecting the 
microvasculature will affect taste.  The microvasculature of the tongue is almost identical 
to the retinal microvasculature and this is the reason why we hypothesize that taste can be 
used as an indirect monitor of the progression of diabetes and in particular diabetic 
retinopathy.  
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Electrogustometer 
The electrogustometer (Figure 5) is a clinical tool that utilizes the topical 
application of weak anodal, DC current that can be applied to lingual and other taste buds 
in the oral cavity (20).  These electrical stimuli can be precisely applied and localized on 
the tongue and provide a good measure of taste sensitivity thresholds (21).  The 
application of anodal current generated by the electrogustometer produces a sour-metallic 
sensation.  The weak anodal DC current is powered by 4 AA batteries, and stimulates the 
taste buds directly with less than 400 μA.  To complete and ground the electrical circuit, a 
plastic clamp with a metal strip is placed on the subject’s non-dominant forearm with a 
water-soluble gel to increase conductivity.  The mechanism of electric taste is thought to 
involve hydrogen ions liberated at the anode which acidifies the saliva in a localized area 
of the tongue due to their combining with the chloride ions in the saliva and thereby 
activating the ionic taste receptors responsible for the sour taste sensation (21).  The 
electrogustometer activates all types of taste buds that have hydrogen ion receptors.   
 
Figure 5. TR-06 Rion Electrogustometer (22). 
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Hypothesis 
The specific hypothesis being tested is presented is: the mean current detected in 
quadrant x for subjects with long-standing diagnosed Type 2 diabetes mellitus is equal to 
the mean current detected in quadrant x for subjects with newly diagnosed Type 2 
diabetes mellitus. 
Goal 
The goal of this proof-of-concept/feasibility study was to determine whether 
differences in taste threshold perception in subjects with newly-diagnosed or long-
standing diagnosed Type 2 diabetes mellitus can be detected and associated with the 
duration of their disease.   
Objectives 
1. Identify appropriate subjects by reviewing the patient records. 
2. Administer subject questionnaire to rule out confounds that would preclude 
participation in this study. 
3. Administer the electrogustometry test to determine taste thresholds in each of four 
quadrants of the dorsal surface of the tongue. 
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Methods and Materials 
This study was approved by the Philadelphia College of Osteopathic Medicine IRB. 
Subjects 
The inclusion criteria for the subjects in this study were newly-diagnosed (< 2 
years) and long-standing diagnosed (> 6 years) male and female Type 2 diabetes mellitus 
subjects greater than 21 years of age and of all ethnic and racial backgrounds. 
The exclusion criteria for subjects in this study were smoking, less than 21 years 
of age, and Type 1 insulin requiring diabetes.  No patients diagnosed with Type 2 
diabetes mellitus of a duration from 2 to 6 years were recruited for this study. 
Procedures 
Recruitment 
 Jeffrey Freeman, DO., Chairman, Division of Endocrinology, Department of 
Internal Medicine, Philadelphia College of Osteopathic Medicine, screened and recruited 
appropriate subjects from his patient population based upon their diagnostic records.  He 
presented the study to the prospective patients and invited them to participate in the 
investigation.  When a patient indicated their willingness to participate; a testing session 
was scheduled.  At the beginning of the testing session, the investigators explained the 
procedure to the subject and answered any questions while obtaining informed consent.  
A personal history/health questionnaire was completed prior to commencing the testing. 
Test Procedures 
 1.  The dorsal surface of the tongue was divided into four test-quadrants by first 
dropping an imaginary perpendicular line through the midline of the tongue along the 
median sulcus extending from the far proximal edge of the circumvallate region to the 
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anterior tip of the tongue.  An imaginary horizontal line was drawn at the midpoint of the 
vertical line while noting landmark features on the tongue’s surface that enabled the 
recognition of these four divisions, so that these boundaries could be preserved, and the 
probe placement sites in each quadrant could be returned to with accuracy for repeated 
measurements.  
 
Figure 6.  A tongue depicting the four test quadrants. 
 2.  Twenty-four hours prior to testing each subject, a test probe was sterilized 
(Cidex, Johnson and Johnson Medical Incorporated, Arlington, TX) according to 
standard procedures. 
 3.  Prior to initiating the actual test, the probe was placed at a location on the 
surface of the tongue excluded from the test area (distal edge of the tongue tip), and the 
highest decibel current was induced so that the patient would be aware of the nature of 
the stimulus (i.e. a dissatisfying sour, metallic-like taste) that they were asked to 
recognize by pressing a hand-held buzzer to indicate their response.   
4.  The test was administered by placing a stimulus probe, 2mm in diameter, 
sequentially in each of the four predetermined quadrants on the tongue surface. 
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 5.  In the first series of measurements, the administration of the current signal was 
controlled by first moving from the lowest intensity (-6 dB) to the highest intensity (34 
dB) with a duration of 2 seconds for every increment of 2 dB.  Each intensity was 
measured in each quadrant, for a total of 84 measurements.  The subject indicated 
perception of the signal (i.e. a dissatisfying sour, metallic-like taste) by pressing a hand-
held buzzer that was electronically coupled to the machine.  In the next series of 
measurements the current signal was administered beginning at the highest intensity to 
the lowest intensity in decrements of 2 dB until the subject indicated the disappearance of 
the stimulus signal (i.e. a dissatisfying sour, metallic-like taste) by pressing a hand-held 
buzzer that was electronically coupled to the machine.  Each intensity was measured in 
each quadrant, for a total of 84 measurements.  In the cases where the subject was unable 
to discern either the presence or disappearance of the signal at any decibel level they 
were assigned as having a taste threshold greater than 34 dB for statistical purposes. 
 Random, sham responses consisting of no electrical stimulus through the probe 
were interspersed randomly to validate the accuracy of the subject’s response.  The 
electrogustometer was turned off for the sham response without the subject’s awareness, 
and the correct response from the subject would be that he or she could not detect a taste 
sensation.  A measurement consisted of placing the probe on a particular site on the 
tongue and turning the machine to a specific intensity where the subject indicated 
perception by pressing a hand-held buzzer.  A mark was made on a table listing the 
intensities perceived.  Each of the four tongue test sites were evaluated in this manner 
with both increasing and decreasing signal intensities.  The subject was provided with a 
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cup of water to rinse their mouth out at will.  Each subject participated in one test session 
of approximately 30 minutes duration. 
 There was no normal or control group.  Prior studies have established the range of 
normal responses of 5-10dB and would be redundant to repeat (1, 3, 23, 24).  The 
investigators used sham responses to prove that the subject actually had the ability to 
taste or not.   
Statistical Analysis 
Descriptive statistics were used to summarize the threshold level of current that 
was perceived by each subject as the intensity was increased and then decreased.  
Descriptive statistics included the number of subjects, arithmetic average current setting, 
standard deviation, median, maximum, and minimum current values, and the lower and 
upper 95% confidence limits.  All of the descriptive statistics are presented by quadrant 
and the duration of diabetes, categorized into 2 mutually-exclusive groups (existing 
diagnosis for >6 years and newly diagnosed within <2 years).  Comparisons of the level 
of current by duration of disease, quadrant, and increasing or decreasing intensity were 
all analyzed using a 1-Factor Analysis of Variance Model (ANOVA).  The intra-subject 
threshold level of detection of increasing and decreasing current served as the dependent 
variable.  Probability values <0.05 were considered significant; probability value <0.1 but 
>0.5 were considered indicative of a consistent ‘trend’ towards significance (Appendix 
A, Table 1 and Appendix B, Table 1 and 2).  A two sample T-test Power Analysis was 
also completed on the data to determine how many subjects would be needed in a larger 
study to obtain statistically significant differences in taste thresholds at the probability 
level of p< 0.05 (Appendix C). 
19 
Results 
 Type 2 diabetes mellitus complications are associated with numerous pathologies 
related to the duration of the disease.  This study was designed to determine whether taste 
thresholds could be affected as a consequence of this disease process.  It would be 
expected that those individuals whose Type 2 diabetes mellitus is long-standing (>6 
years) would have higher taste thresholds indicative of a decreased taste sensitivity. 
 Although no significant difference in taste thresholds was found between newly 
diagnosed and long-standing diagnosed diabetics, when quadrant by quadrant 
comparisons were made between the two groups, a definite trend was apparent (p>0.05 
but <0.10).  With the exception of decreased current application in quadrant 3, every 
other measurement reflected a higher threshold in taste sensitivity for every quadrant of 
the tongue in the long-standing diagnosed diabetic subjects.  However, when the data for 
increasing current application was combined for all 4 quadrants in each group, a 
significant difference was found for these subjects with long-standing disease having the 
higher taste thresholds (p=0.005)(Figure 7). 
These results reflect determinations obtained from 11 subjects, grouped according 
to the duration of their disease i.e. whether their Type 2 diabetes mellitus had been 
diagnosed longer than 6 years ago (6 subjects) or whether their Type 2 diabetes mellitus 
had been newly diagnosed less than 2 years ago (5 subjects).  Table 1 contains the raw 
data obtained for each individual quadrant and threshold response for both increasing and 
decreasing threshold determinations from the subjects in the study.  Each subject’s taste 
threshold is listed according to the increasing or decreasing current that was applied, with 
means and standard deviations for the groups long-standing and newly diagnosed 
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diabetics included in order to show each subject’s relative placement with respect to the 
group mean. 
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Figure 7. Electrogustometry results in subjects with newly diagnosed (< 2 years) and long-standing diagnosed (>6 years) Type 2 
diabetes mellitus subjects.  The current was at time of perception with mean at 95% confidence intervals.  
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Graphic No. 1.0: CURRENT AT THE TIME OF PERCEPTION (mean with 95% confidence limits)
C
u
rr
e
n
t
Probability values are derived from a 1 factor (duration of disease) analysis of variance test.
Increasing Current: P=0.005 
Decreasing Current: P=0.749 
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Electrogustometry Raw Data Obtained from Type 2 Diabetic Subjects 
Table 1.  Subject raw data obtained from study with relative comparison to overall means 
and standard deviations of each quadrant for increasing and decreasing input current. 
 
  
Subject 
↑Current 
Threshold (dB) Mean 
Standard 
Deviation 
↓ Current 
Threshold (dB) Mean 
Standard 
Deviation 
Q
u
a
d
ra
n
t 
1
 N
ew
ly
 
D
ia
g
n
o
se
d
 
(<
2
 y
r)
 
1 34 dB (no taste) 
22.8 9.86 
34  (no taste) 
29.6 6.19 
2 24 dB 30 
3 16 dB 20 
4 30 dB 34  (no taste) 
5 10 dB 28 
E
x
is
ti
n
g
 
D
ia
g
n
o
si
s 
  
  
  
  
(>
6
 y
r)
 
1 18 
30.17 6.91 
26 
33.17 3.54 
2 26 34 
3 34 (no taste) 34 (no taste) 
4 34 (no taste) 34 (no taste) 
5 34 (no taste) 34 
6 32 34 
Q
u
a
d
ra
n
t 
2
 N
ew
ly
 
D
ia
g
n
o
se
d
 
(<
2
 y
r)
 
1 34 (no taste) 
16.8 16.69 
34 (no taste) 
25.6 13.13 
2 6 18 
3 2 6 
4 34 34 (no taste) 
5 6 34 
E
x
is
ti
n
g
 
D
ia
g
n
o
si
s 
  
  
  
  
(>
6
 y
r)
 
1 18 
27.83 6.46 
26 
29 7.21 
2 26 16 
3 34 (no taste) 34 (no taste) 
4 34 34 (no taste) 
5 24 32 
6 30 30 
Q
u
a
d
ra
n
t 
3
 N
ew
ly
 
D
ia
g
n
o
se
d
 
(<
2
 y
r)
 
1 34  (no taste) 
17.2 16.51 
34 (no taste) 
33.6 2.07 
2 4 34 
3 2 30 
4 34 34 (no taste) 
5 10 34 
E
x
is
ti
n
g
 
D
ia
g
n
o
si
s 
  
  
  
  
(>
6
 y
r)
 
1 24 
29.83 5.71 
22 
28 6.9 
2 24 34 (no taste) 
3 34 (no taste) 34 (no taste) 
4 34 (no taste) 30 
5 34 (no taste) 18 
6 26 28 
Q
u
a
d
ra
n
t 
4
 N
ew
ly
 
D
ia
g
n
o
se
d
 
(<
2
 y
r)
 
1 34 (no taste) 
19.6 15.5 
34 (no taste) 
30 7.31 
2 20 28 
3 4 18 
4 34 34 (no taste) 
5 4 34 
E
x
is
ti
n
g
 
D
ia
g
n
o
si
s 
  
  
  
  
(>
6
 y
r)
 
1 26 
26.67 9.67 
22 
31.33 4.97 
2 16 34 (no taste) 
3 34 (no taste) 34 (no taste) 
4 34 (no taste) 32 
5 14 30 
6 34 34 
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 The mean taste thresholds for Quadrant 1 are shown below in Fig. 8.  For the 
increasing output currents, the long-standing diagnosed diabetics had a higher mean taste 
threshold value of 30.17 decibels (dB) compared to 22.80 dB mean taste threshold value 
for the newly-diagnosed diabetic subjects.  For decreasing output current, the long-
standing diabetics had a mean taste threshold value of 33.17 dB which was higher than 
the 29.60 dB mean taste threshold value for the newly-diagnosed diabetic subjects.    
 
 
Figure 8. Quadrant 1 Mean Taste Thresholds Measured in Decibels (dB) with 
Decreasing and Increasing Output Current for both Newly-Diagnosed (< 2 years) and 
Long-standing Diagnosed (> 6 years) Type 2 diabetes mellitus subjects. 
  
 
 
 
 
 
24 
The mean taste thresholds for Quadrant 2 are shown below in Fig. 9.  For the 
increasing output currents, the long-standing diagnosed diabetics had a higher mean taste 
threshold value of 27.83 dB compared to 16.80 dB mean taste threshold value for the 
newly-diagnosed diabetic subjects.  In the decreasing output current, the long-standing 
diabetics had a mean taste threshold value of 29.00 dB which was higher than the 25.60 
dB mean taste threshold value for the newly-diagnosed diabetic subjects.    
 
 
Figure 9. Quadrant 2 Mean Taste Thresholds Measured in Decibels (dB) With 
Decreasing and Increasing Output Current for both Newly-Diagnosed (< 2 years) and 
Long-standing Diagnosed (> 6 years) Type 2 diabetes mellitus subjects.  
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The mean taste thresholds for Quadrant 3 are shown below in Fig. 10.  For the 
decreasing output current, the long-standing diagnosed diabetics had a lower mean taste 
threshold value of 28.00 dB compared to 33.60 dB mean taste threshold value for the 
newly-diagnosed subjects.  It was the opposite case when increasing output current; the 
long-standing diabetics had a mean taste threshold value of 29.83 dB which was higher 
than the 17.20 dB mean taste threshold value for the newly-diagnosed diabetic subjects.  
 
 
Figure 10. Quadrant 3 Mean Taste Thresholds Measured in Decibels (dB) With 
Decreasing and Increasing Output Current for both Newly-Diagnosed (< 2 years) and 
Long-standing Diagnosed (> 6 years) Type 2 diabetes mellitus subjects. 
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The mean taste thresholds for Quadrant 4 are shown below in Fig. 11.  For the 
increasing output currents, the long-standing diagnosed diabetics had a higher threshold 
value of 26.67 dB compared to 19.60 dB mean taste threshold value for the newly-
diagnosed diabetic subjects.  In the decreasing output current, the long-standing diabetics 
had a mean taste threshold value of 31.33 dB which was higher than the 30.00 dB mean 
taste threshold value for the newly-diagnosed diabetic subjects.  
 
 
 
Figure 11.  Quadrant 4 Mean Taste Thresholds Measured in Decibels (dB) With 
Decreasing and Increasing Output Current for both Newly-Diagnosed (< 2 years) and 
Long-standing Diagnosed (> 6 years) Type 2 diabetes mellitus subjects. 
 
Summary: Although no significant differences in taste thresholds were found 
between newly-diagnosed and long-standing diagnosed diabetics when comparisons were 
made quadrant by quadrant using a univariate analysis, a definite trend towards 
decreasing sensitivity was seen from these comparisons (Appendix A).  With the 
exception of threshold determination by decreased current application in Quadrant 3 
every other threshold determination reflected a higher threshold in taste sensitivity in the 
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long-standing diabetic subjects in every quadrant of the tongue.  An additional univariate 
analysis was performed after grouping the data for all four quadrants of each subject into 
results for either increasing or decreasing current application.  No consistent distribution 
of the subjects in either group towards an increased taste threshold was detected 
(Appendix B Table 1).  However, when the threshold data for increasing current 
application was combined for all 4 quadrants of each subject in the newly diagnosed 
group and compared to a similar combination for the long-standing diagnosed group a 
significantly higher taste threshold was detected in the latter group (p=0.005).   
Initial analysis of the data was performed by completing a one Factor Analysis of 
Variance comparing each quadrant individually for both increasing and decreasing 
current application in subjects with newly diagnosed and long-standing diagnosed Type 2 
diabetes mellitus (Appendix B Table 1).  The results of this analysis did not confirm a 
significant difference between the two populations.  However when a one Factor 
Analysis of Variance was applied to the combined data for each group a significantly 
elevated taste threshold was demonstrated, p=0.005 (Appendix B Table 2).   
Based upon the number of subjects included in this proof of concept/feasibility 
study a Two-Sample T-Test Power Analysis was applied to determine how many 
additional subjects would be needed to obtain statistical significance for comparisons 
between groups for each quadrant (Appendix C):  
1. Decreasing current application - 32 subjects for Quadrant 1,  
                                                                      153 subjects for Quadrant 2,  
                                                                      21 subjects for Quadrant 3, and  
          364 subjects for Quadrant 4.   
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2. Increasing current application - 22 subjects for Quadrant 1,  
         23 subjects for Quadrant 2,  
        17 subjects for Quadrant 3, and  
        54 subjects for Quadrant 4 (Appendix C). 
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Discussion 
This study was undertaken to address the lack of non-invasive, cost-effective 
methods to assess the status and progression of Type 2 diabetes mellitus.  Presently, 
blood tests for glucose levels and glycosylated hemoglobin are the standard methods used 
to monitor patients.  
Changes in taste threshold sensitivity using electrogustometry may provide an 
alternative approach to monitor the progression of Type 2 diabetes since these results 
suggest that differences in taste threshold sensitivity may be related to the duration of the 
disease.  This study was a proof-of-concept study, with a small number of subjects 
enrolled and evaluated and the results warrant further investigation.  The rationale for 
increasing the number of test subjects would be to facilitate subject matching by factors 
such as ethnicity and lifestyle which all may be variables that contribute to changes in 
taste threshold sensitivity.    
Confounds  
Several confounds of communication, severity of the disease, demographics, 
uncertain date of disease onset, and unanticipated events were present in this study. 
Communication  
Despite initial queries of each potential subject regarding their smoking habits – 
patients were later found by the other investigators to be smokers, immediately prior to 
testing.  One probable explanation for the withholding of this information could have 
been their reluctance to admit this behavior to their physician.  These subjects were 
removed from the study since smoking has been shown to affect taste and was part of the 
exclusion criteria for subjects to participate in this study (25). 
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Severity of the disease 
Some subjects with long-standing Type 2 diabetes were unable to detect the stimulus 
delivered by the electrogustometer.  Apparently, their taste thresholds exceeded the 
ability of the instrument to generate a large enough signal to be detected.  The 
electrogustometer only has a maximum current output of 34 decibels, and some 
longstanding diagnosed subjects could not perceive this stimulus.  Anecdotal information 
indicated that they probably did have much higher thresholds.  This was evidenced by 
comments such as “having trouble tasting on occasion,” and one of these subjects also 
had wound healing difficulties.  Both factors point towards possible compromised 
circulation that may have contributed to their inability to detect the stimuli. 
Demographics 
The subjects were chosen solely on the basis of disease duration; less than 2 years or 
greater than 6 years.  None of the subjects in either group were matched according to age, 
sex, ethnicity, lifestyle, or any other variable.  Individual subjects were taking 
medications to treat conditions other than those directly related to their Type 2 diabetes 
mellitus.  These additional medications also could have affected taste sensitivity.  Most 
subjects had hypertension and hypercholesterolemia and were on medications for these 
conditions.   
Uncertain date of disease onset 
Perhaps the diabetes in “newly diagnosed” subjects went undetected for an extended 
period of time before they were officially diagnosed by a physician.  Their taste 
sensitivity may have already been compromised by their disease.   
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Unanticipated events  
Two incidents involved the use of chairs with metal arms in which the subjects 
were seated during testing.  One subject evidenced a unique response to the testing.  The 
subject mentioned a tingling sensation on the arm, provoked by the delivery of the 
stimulus to the tongue, at the site on his arm where the ground clamp was placed.  When 
questioned, the subject stated that there was a metal plate placed in his forearm when a 
bone break was repaired many years prior to this test.  The ground clamp was moved to 
the opposite arm, but a similar sensation was evoked in that same location as before when 
the current was applied through the probe to the tongue.  It was hypothesized that the 
metal plate provided a pathway of lesser resistance for the current and dissipated the 
energy directed at the tongue site.  Due to the unique nature of the result with this subject, 
testing was ceased immediately, and the data was not included in this study. 
Another subject also evidenced a unique response to the testing.  The subject 
mentioned a tingling sensation on the arm, provoked by the delivery of the stimulus to the 
tongue, at the site on her arm where the ground clamp was placed.  The subject did have a 
metal watch and jewelry on the same arm as the ground clamp.  The subject was required 
to remove the watch and jewelry, and the testing resumed.  Again, the subject stated there 
was a tingling sensation on the arm with the ground clamp when the current was turned 
on.  The subject then was instructed to place the arm with the ground clamp on their lap 
instead of on the metal arm of the chair they were seated in.  The testing resumed from 
the beginning, and finally no more sensations were experienced in the arm with the 
ground clamp.  The resulting data was included in the analysis.  After the second incident 
occurred, it was determined that metal arm of the chair was causing interference, 
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grounding the subject, so all future testing had the subjects seated on a wood based 
examination table. 
Conclusions  
Even with all of the variables factored into the study, we were still able to detect a 
trend, that the long-standing diagnosed diabetics had a decreased taste sensitivity 
compared to the newly-diagnosed diabetics.  This trend was similar for Quadrants 1, 2, 
and 4 in the delivery of decreasing and increasing output currents and in Quadrant 3 only 
with the increasing output.  For the delivery of decreasing output current, the trend was 
opposite; newly-diagnosed subjects had a higher mean taste threshold value in Quadrant 
3 than the long-standing diagnosed subjects.  What is unusual is that this was a unilateral 
difference not bilateral.  Both posterior quadrants 1 and 3 are innervated by the chorda 
tympani nerve, why only one side was affected is not apparent.   
As stated previously, reasons for only the increasing current data being 
statistically significant and not the decreasing current was most likely due to the small 
subject population, and the inability to match the two groups of diabetics to one another.  
Repeated testing on each subject would give a better understanding of the precision of the 
observations in each quadrant. 
Continuing this study with an enhanced number of more closely matched subjects 
as well as repeated testing of the same subject is certainly feasible as it is both cost and 
time-effective.  Statistically significant results from a larger study would confirm the 
value of this test for physicians managing their Type 2 diabetic patients in their office 
environment and would complement the current routine laboratory tests used to monitor 
the severity of the disease.   
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Although the duration and limited number of subjects enrolled in this preliminary 
study limited the number of assumptions that could be confirmed, sufficient evidence of a 
correlation between taste thresholds and duration of disease was obtained to warrant an 
expanded investigation.   
 
 
 
 
 
 
 
34 
References 
1. Brownlee, R. (2008). Electrogustometry taste-threshold detection in type I and 
type II diabetes. Unpublished MS, Philadelphia College of Osteopathic Medicine.  
2. Perros, P., MacFarlane, W., Counsell, C., Frier, B. (1996). Altered taste sensation 
in newly-diagnosed NIDDM. Diabetes Care, 19(7), 768-770. 
3. Joseph, M. Comparison of taste thresholds by electrogustometry and PTC 
(Phenylthiocarbamide) sensitivity between non-diabetic volunteers with and 
without a familial history of diabetes, manuscript in preparation, 2010. 
4. Guyton, A., & Hall, J. (2005). Insulin, glucagon, and diabetes mellitus. Guyton & 
hall: Textbook of medical physiology (12th ed.). Philadelphia, PA: Elsevier 
Saunders.  
5. Powers, A. Chapter 338. Diabetes mellitus (chapter). In A. S. Fauci, et al. (Eds.), 
Harrison's priniciples of internal medicine (17th ed., ) Retrieved from 
http://ezproxy.pcom.edu:2054/content.aspx?aID=2891108 
6. Scanlon, V., & Sanders, T. (2007). The endocrine system. Essentials of anatomy 
and physiology (5th ed., ) 
7. Crandall, J. (2006). Hypoglycemia. Merck manuals online medical library (Home 
ed.) Merck and Co., Inc.  
8. Molina, P. E. (2006). Endocrine pancreas. Endocrine physiology (2nd ed.,) The 
McGraw-Hill Companies.   
9. American Diabetes Association. Other diabetes medications. Retrieved May 20, 
2009, from http://www.diabetes.org/type-2-diabetes/oral-medications.jsp 
35 
10. The Diabetes Control and Complications Trial Research Group. (1993). The 
effect of intensive treatment of diabetes on the development and progression of 
long-term complications in insulin-dependent diabetes mellitus. New England 
Journal of Medicine, 329, 977-986. 
11. UK Prospective Diabetes Study Group. (1998). Intensive blood-glucose control 
with sulfonylureas or insulin compared with conventional treatment and risk of 
complications in patients with type 2 diabetes. Lancet, 352, 837-853. 
12. Shichiri, M. (2000). Long-term results of the Kumamoto study on optimal 
diabetes control in type 2 diabetic patients. Diabetes Care, 23(Supplement 2), 
B21-B29.  
13. Aring, A. M., Jones, D. E., & Falko, J. M. (2005). Evaluation and prevention of 
diabetic neuropathy. American Family Physician, 71(11), 2123-2128. 
14. Vernino, S., & Freeman, R. (2007). Peripheral autonomic neuropathies. 
Continuum Lifelong Learning Neurology, 13(6), 89-110.   
15. Mayo Clinic Staff. (2008). Diabetic retinopathy. Retrieved Oct. 6, 2008, from 
http://www.mayoclinic.com/health/diabetic-retinopathy/ds00447 
16. Netter, F. (2006). Atlas of Human Anatomy, 4th ed.  
17. Ganong, W. F. Chapter 10. Smell & taste (chapter). Ganong WF: Review of 
medical physiology (22nd ed., ) 
18. Wenner, M. (2008). Magnifying taste. Scientific American, 299(2), 96-99.  
19. Guyton, A., & Hall, J. (2005). The chemical senses - taste and smell. Guyton & 
Hall: Textbook of medical physiology (11th ed.). Philadelphia, PA: Elsevier 
Saunders.  
36 
20. Frank, M., & Smith, D. (1991). Electrogustometry: A simple way to test taste. In 
T. Getchell (Ed.), Smell and taste in health and disease (pp. 503-514). New York: 
Raven Press. 
21. Stillman, J. A., Morton, R. P., Hay, K. D., Ahmad, Z., & Goldsmith, D. (2003). 
Electrogustometry: Strengths, weaknesses, and clinical evidence of stimulus 
boundaries. Clinical Otolaryngology & Allied Sciences, 28(5), 406. 
22. Sensonics, Inc. (2008). TR-06Rion Electrogustometer. Retrieved June 5, 2009, 
from 
http://www.sensonics.com/shop/pc/viewPrd.asp?idcategory=6&idproduct=29  
23. Pavlos, Pavlidis, Nikolaidis Vasilios, Anogeianaki Antonia, Koutsonikolas 
Dimitrios, Kekes Georgios, and Anogianakis Georgios. (2009). Evaluation of 
Young Smokers and Non-smokers with Electrogustometry and Contact 
Endoscopy. BMC Ear, Nose and Throat Disorders 9(9).  
24. Le Mouel, C., A. Olivia, P. Giry, A. Angot, and P. Renon. (1977). 
Electrogustometric Threshold in Diabetes Mellitus and Chronic Alcoholism. Ann. 
Oto-Laryng. (Paris) 94(12), 715-24.  
25. Tomassini, S., Cuoghi, V., Catalani, E., Casini, G., & Bigiani, A. (2007). Long-
term effects of nicotine on rat fungiform taste buds. Neuroscience, 147(3), 803-
810.  
  37 
APPENDIX A 
ELECTROGUSTOMETRY RESULTS IN PATIENTS WITH NEW (<2 YEARS) AND EXISTING (>6 YEARS) TYPE 2 DIABETES 
UNIVARIATE ANALYSIS BY QUADRANT, INCREASING OR DECREASING CURRENT, AND DURATION OF DISEASE 
QUADRANT 
INCREASING/ 
DECREASING 
CURRENT 
DURATION OF DISEASE N 
ARITHMETIC 
AVERAGE 
STANDARD 
DEVIATION 
MEDIAN 
MIN. 
VALUE 
MAX. 
VALUE 
95% CONFIDENCE 
INTERVALS 
LOWER UPPER 
QUADRANT 1 DECREASING 
EXISTING DIAGNOSIS >6 
YRS 
6 33.17 3.54 34.50 26.00 35.00 29.45 36.89 
QUADRANT 1 DECREASING NEWLY DIAGNOSED <2 YRS 5 29.60 6.19 30.00 20.00 35.00 21.92 37.28 
QUADRANT 1 INCREASING 
EXISTING DIAGNOSIS >6 
YRS 
6 30.17 6.91 33.50 18.00 35.00 22.91 37.42 
QUADRANT 1 INCREASING NEWLY DIAGNOSED <2 YRS 5 22.80 9.86 24.00 10.00 34.00 10.56 35.04 
QUADRANT 2 DECREASING 
EXISTING DIAGNOSIS >6 
YRS 
6 29.00 7.21 31.00 16.00 35.00 21.43 36.57 
QUADRANT 2 DECREASING NEWLY DIAGNOSED <2 YRS 5 25.60 13.13 34.00 6.00 35.00 9.30 41.90 
QUADRANT 2 INCREASING 
EXISTING DIAGNOSIS >6 
YRS 
6 27.83 6.46 28.00 18.00 35.00 21.05 34.62 
QUADRANT 2 INCREASING NEWLY DIAGNOSED <2 YRS 5 16.80 16.69 6.00 2.00 35.00 -3.93 37.53 
QUADRANT 3 DECREASING 
EXISTING DIAGNOSIS >6 
YRS 
6 28.00 6.90 29.00 18.00 35.00 20.76 35.24 
QUADRANT 3 DECREASING NEWLY DIAGNOSED <2 YRS 5 33.60 2.07 34.00 30.00 35.00 31.03 36.17 
QUADRANT 3 INCREASING 
EXISTING DIAGNOSIS >6 
YRS 
6 29.83 5.71 30.50 24.00 35.00 23.84 35.82 
QUADRANT 3 INCREASING NEWLY DIAGNOSED <2 YRS 5 17.20 16.51 10.00 2.00 35.00 -3.30 37.70 
QUADRANT 4 DECREASING 
EXISTING DIAGNOSIS >6 
YRS 
6 31.33 4.97 33.00 22.00 35.00 26.12 36.55 
QUADRANT 4 DECREASING NEWLY DIAGNOSED <2 YRS 5 30.00 7.31 34.00 18.00 35.00 20.92 39.08 
QUADRANT 4 INCREASING 
EXISTING DIAGNOSIS >6 
YRS 
6 26.67 9.67 30.00 14.00 35.00 16.52 36.81 
QUADRANT 4 INCREASING NEWLY DIAGNOSED <2 YRS 5 19.60 15.50 20.00 4.00 35.00 0.35 38.85 
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Appendix B. 
ELECTROGUSTOMETRY RESULTS IN PATIENTS WITH NEW (<2 YEARS) AND EXISTING (>6 YEARS) TYPE II DIABETES   
TABLE 1: UNIVARIATE ANALYSIS BY INCREASING OR DECREASING CURRENT, AND DURATION OF DISEASE 
          
INCREASING/ 
DECREASING 
CURRENT 
DURATION OF 
DISEASE 
N 
ARITHMETIC 
AVERAGE 
STANDARD 
DEVIATION 
MEDIAN 
MIN. 
VALUE 
MAX. 
VALUE 
95% CONFIDENCE 
INTERVALS 
LOWER UPPER 
DECREASING 
EXISTING 
DIAGNOSIS >6 YRS 
24 30.38 5.83 33.00 16.00 35.00 27.91 32.84 
DECREASING 
NEWLY 
DIAGNOSED <2 YRS 
20 29.70 8.06 34.00 6.00 35.00 25.93 33.47 
INCREASING 
EXISTING 
DIAGNOSIS >6 YRS 
24 28.63 7.00 31.00 14.00 35.00 25.67 31.58 
INCREASING 
NEWLY 
DIAGNOSED <2 YRS 
20 19.10 13.90 18.00 2.00 35.00 12.60 25.60 
 
ELECTROGUSTOMETRY RESULTS IN PATIENTS WITH NEW (<2 YEARS) AND EXISTING (>6 YEARS) TYPE II DIABETES   
TABLE 2: RESULTS FROM THE ONE-FACTOR [DISEASE] ANALYSIS OF VARIANCE TESTS PERFORMED ON THE 
THRESHOLD VALUES BY INCREASING OR DECREASING CURRENT 
     
INCREASING OR 
DECREASING 
CURRENT 
DEGREES OF 
FREEDOM 
TYPE III SUMS OF 
SQUARES 
F-VALUE PROBABILITY VALUE 
DECREASING 1 4.970455 0.1036 0.749 
INCREASING 1 989.734091 8.6648 0.005 
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Appendix C. Two-Sample T-Test Power Analysis 
Table 2.  Two-sample T-test for decreasing and increasing current.  The number of subjects needed to attain a power 80%; meaning 
80% of the time it would be possible to detect a significant difference if a significant difference existed.  N1 and N2 are the sample 
sizes needed.  Alpha = default significance level of 0.05.  Beta is used in calculating the power of the test.  S1 and S2 are the standard 
deviations for mean 1 and 2 respectively. 
 
For both Decreasing and Increasing Currents and all quadrants the following applies:                    
 Null Hypothesis: Mean1=Mean2,  
 Alternative Hypothesis: Mean1<>Mean2, 
 The standard deviations were assumed to be unknown and unequal.   
 The following tables list the numeric results for Two-Sample T-Test. 
 
 
DECREASING CURRENT 
    
Allocation 
       Power N1 N2 Ratio Alpha Beta Mean 1 Mean 2 S1 S2 
Quadrant 1 0.80098 32 32 1.000 0.05000 0.19979 30.4 29.7 5.8 8.1 
Quadrant 2 0.80012 153 153 1.000 0.05000 0.19988 29.0 25.6 7.2 13.1 
Quadrant 3 0.80074 21 21 1.000 0.05000 0.19926 29.0 33.6 6.9 2.1 
Quadrant 4 0.80029 364 364 1.000 0.05000 0.19971 31.3 30.0 5.0 7.3 
INCREASING CURRENT 
    
Allocation 
       Power N1 N2 Ratio Alpha Beta Mean 1 Mean 2 S1 S2 
Quadrant 1 0.80094 22 22 1.000 0.05000 0.19906 30.2 22.8 6.9 9.9 
Quadrant 2 0.81206 23 23 1.000 0.05000 0.18794 27.8 16.8 6.5 16.7 
Quadrant 3 0.80848 17 17 1.000 0.05000 0.19152 29.8 17.2 5.7 16.5 
Quadrant 4 0.80592 54 54 1.000 0.05000 0.19408 26.7 19.6 9.7 15.5 
40 
Appendix D. Subject Health History Questions and Answers 
All subjects were non-smokers and never had any injuries/diseases of the tongue and/or oral cavity. 
Subject Gender Age Type 
2 
Diagnosed Family 
History 
Glucose 
study 
done? 
Suffer from 
metabolic 
diseases? 
Ethnicity Height Weight 
(lbs) 
BMI 
1 M 49 Yes 3 months Yes (Father) No No Caucasian 5’11” 235 32.8 
2 M 57 Yes 2 yrs 3 
months 
No No No African-
American 
6’1” 230 30.3 
3 M 60 Yes 6 yrs No No No Caucasian 6’2” 260 33.4 
4 M 50 Yes 10 years Yes (Father, 
sister, brother) 
Yes No Caucasian 6’0” 240 32.5 
5 M 71 Yes 15 years Yes (Mother) No No African-
American 
6’1” 194 25.6 
6 M 37 Yes 1.5 years No No Yes (Metabolic 
syndrome) 
Caucasian 5’9” 270 39.9 
7 F 48 Yes 20 years Yes (Mother) No No African-
American 
5’3” 228 40.4 
8 F 73 Yes 8 years No No No African-
American 
5’5” 142 23.6 
9 F 52 Yes 6 months Yes (Father & 
Mother) 
Yes No African-
American 
5’5” 202 33.6 
10 F 69 Yes 6 years Yes (Mother, 
Father, and 
Siblings) 
No No Caucasian 5’6” 217 35.0 
11 F 63 Yes 1 year 4 
months 
Yes (Father, 
Grandmother 
father’s side) 
No No Caucasian 5’0” 195 38.1 
 
